Clinical Trial Update: A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Patients With Severe Sepsis [Phase 1, Phase 2]

View source ↗

Summary

Reported completion of a Phase IIb trial evaluating the efficacy and safety of an unnamed study drug in patients with severe sepsis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Snippet

Sponsor: Eli Lilly and Company | Conditions: Sepsis | Phase 1, Phase 2 | Status: COMPLETED